- S. Miura and S. Izuta, DNA polymerases as targets of anticancer nucleosides. Curr. Drug Targets,
2004, 5 , 191–195. - I.M. Kompis, K. Islam and R.L. Then, DNA and RNA synthesis: Antifolates. Chem. Rev., 2005, 105 ,
593–620. - D.R. Newell, How to develop a successful cancer drug – molecules to medicines or targets to
treatments? Eur. J. Cancer, 2005, 41 , 676–682. - S.L. Gerson, Clinical relevance of MGMT in the treatment of cancer. J. Clin. Oncol., 2002, 20 ,
2388–2399. - E. DeClercq, Antiviral drugs in current clinical use. J. Clin. Virol., 2004, 30 , 115–133.
- J.S. Copperwood, G. Gumina, F.D. Boudinot and C.K. Chu, in Recent Advances in Nucleosides:
Chemistry and Chemotherapy. C.K. Chu (ed), Elsevier, Amsterdam, 2002, 91–147. - S.G. Sarafianos, K. Das, A.D. Clark, J.P. Ding, P.L. Boyer, S.H. Hughes and E. Arnold, Lamivudine
(3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with
beta-branched amino acids. Proc. Natl. Acad. Sci. USA, 1999, 96 , 10027–10032. - E. De Clercq, Non-nucleoside reverse transcriptase inhibitors (NNRTIs): Past, present, and future.
Chem. Biodivers., 2004, 1 , 44–64. - C. Orkin, J. Stebbing, M. Nelson, M. Bower, M. Johnson, S. Mandalia, R. Jones, G. Moyle,
M. Fisher and B. Gazzard, A randomized study comparing a three- and four-drug HAART regimen
in first-line therapy (QUAD study). J. Antimicrob. Chemother., 2005, 55 , 246–251. - J.A. Bartlett, R. DeMasi, J. Quinn, C. Moxham and F. Rousseau, Overview of the effectiveness of
triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS, 2001, 15 , 1369–1377. - A. Hóly, in Recent Advances in Nucleosides: Chemistry and Chemotherapy.C.K. Chu (ed), Elsevier,
Amsterdam, 2002, 167–238. - E. DeClercq and R.T. Walker, Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside
analogs. Pharmacol. Ther., 1984, 26 , 1–44. - E. DeClercq, Recent Advances in Nucleosides: Chemistry and Chemotherapy.Elsevier, Amsterdam,
2002, 433–454. - R.W. Sidwell, Jt. Witkowsk, L.B. Allen, R.K. Robins, G.P. Khare and J.H. Huffman, Broad-
spectrum antiviral activity of virazole – 1--D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science,
1972, 177 , 705–706. - N.H. Williams and P. Wyman, Base catalysed phosphate diester hydrolysis. Chem. Commun., 2001,
1268–1269. - C. Lad, N.H. Williams and R. Wolfenden, The rate of hydrolysis of phosphomonoester dianions and
the exceptional catalytic proficiencies of protein and inositol phosphatases. Proc. Natl. Acad. Sci.
USA, 2003, 100 , 5607–5610. - P.W. Barnard, C.A. Bunton, D.R. Llewellyn, C.A. Vernon and V.A. Welch, The reactions of organic
phosphates. Part IV. Oxygen exchange between water and orthophosphoric acid. J. Chem. Soc.,
1961, 2670–2676. - A.J. Kirby and M. Younas, Reactivity of phosphate esters – diester hydrolysis. J. Chem. Soc. B, 1970,
510–513. - E.T. Kaiser and K. Kudo, Alkaline hydrolysis of aromatic esters of phosphoric acid. J. Amer. Chem.
Soc., 1967, 89 , 6725–6728. - A.J. Kirby and A.G. Varvoglis, The reactivity of phosphate esters. Monoester hydrolysis. J. Am.
Chem. Soc., 1967, 89 , 415–423. - J. Kumamoto, J.R. Cox and F.H. Westheimer, Barium ethylene phosphate. J. Am. Chem. Soc., 1956,
78 , 4858–4860.
142 Chapter 3